Acquisition Target August Research was acquired by Everest Clinical Research Services in November 2023, signaling consolidation in the CRO space and potential access to Everest’s broader client base and resources for cross-selling in Europe.

European Focus Specialized in European trials with deep expertise in Central and Eastern Europe, presenting an opportunity to expand sponsors’ footprint in these regions through enhanced site management and regulatory efficiency.

Full-Service PV Comprehensive pharmacovigilance offering including safety plans, database management, case entry and reporting, which can be packaged with regulatory and monitoring services to increase deal size with existing and new clients.

Boutique Scale Smaller firm size (11-50 employees) combined with long-tenured management presents a relationship-driven sales angle, ideal for tiered service packages and higher-touch engagements with mid-market sponsors.

Financial Standing Revenue in the $10–$25 million range and recent acquisition indicate market viability and potential for growth-focused opportunities, including upsell on expanded trial scopes or longer-duration studies.